Active Ingredient History

NOW
  • Now
Raltitrexed is an antimetabolite drug used in cancer chemotherapy. It is an inhibitor of thymidylate synthase, and is manufactured by AstraZeneca.   Wikipedia

  • SMILES: CN(Cc1ccc2NC(=NC(=O)c2c1)C)c3ccc(s3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
  • InChIKey: IVTVGDXNLFLDRM-HNNXBMFYSA-N
  • Mol. Mass: 458.5
  • ALogP: 1.98
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

Australia

$202.1285
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

arkomédika brand of raltitrexed | astrazeneca brand of raltitrexed | d1694 | d 1694 | d-1694 | ici d1694 | ici-d1694 | n-(5-(n-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-n-methylamino)-2-thenoyl)-l-glutamic acid | ralitrexed | raltitrexed | tomudex | zd-16 | zd1694 | zd 1694 | zd-1694 | zeneca brand of raltitrexed

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue